Other languages Evogene Ltd. Nasdaq

Equities

EVGN

IL0011050551

Market Closed - Nasdaq Other stock markets 15:59:56 2024-06-06 EDT			5-day change	1st Jan Change
0.68 ^USD	-3.00%		-11.24%	-19.05%

05-23	Earnings Flash (EVGN) EVOGENE Posts Q1 Revenue $4.2M, vs. Street Est of $3.5M	MT
05-23	Evogene Ltd. Provides Revenue Guidance for the Year 2024	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Evogene Ltd. Provides Revenue Guidance for the Year 2024	05-23
Evogene Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-23
Evogene Ltd. and The Kitchen FoodTech Hub Establishes Finally Foods Ltd	04-02
Evogene Receives Minimum Bid Price Non-Compliance Notice From Nasdaq	03-20
Evogene Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-07
Evogene Ltd. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	03-07
Evogene Unit, Corteva Agriscience Identify New Potential Class of Herbicidal Molecules	03-06
AgPlenus Achieves Milestone in Collaboration with Corteva to Develop Novel Herbicides	03-06
Casterra Announces New Agreements with Subsidiary of Evogen Ltd., to Meet Growing Demand for Its Elite Castor Seed Varieties	03-05
Evogene Files $200 Million Mixed Shelf	03-01
Evogene Ltd. and Verb Biotics LLC Enters into Collaboration Agreement	02-06
Casterra Ag Ltd., a subsidiary of Evogene Ltd Announces Executive Changes, Effective January 1, 2024	12-19
Evogene Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-15
Colors Farm Ltd, Evogene Ltd. and Ben-Gurion University Collaborate to Establish Crustacean Gene Editing Technology	23-10-31
Evogene Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-17
Evogene Ltd 's ChemPass AI Tech-Engine is Introduces with New Breakthrough Machine Learning Technology for Target-Protein Discovery	23-07-25
Biomica Ltd. Reports Interim Positive Results from Pre-Clinical Studies in its IBS Program	23-07-19
Evogene Expects to Raise $8.5 Million in Gross Proceeds From Registered Direct Offering; Shares Fall	23-07-17
Evogene's Lavie Bio Says Corteva to Develop, Commercialize Lead Fungicide Product Candidates	23-07-17
Evogene Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-18

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Evogene Ltd. Nasdaq

Equities

EVGN

IL0011050551

Other languages

Filters